ALL HYPOTHESES
Repurposing candidates for alemtuzumab
Inflammatory bowel disease 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| anti-drug antibodies | loss of response | 0.208 | Mid | novel signal | none |
ALL HYPOTHESES
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| anti-drug antibodies | loss of response | 0.208 | Mid | novel signal | none |